Selected article for: "public health and significant burden"

Author: Rehman, Syed Tabish; Rehman, Hareem; Abid, Shahab
Title: Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C
  • Cord-id: t6etzql7
  • Document date: 2021_7_27
  • ID: t6etzql7
    Snippet: The coronavirus disease 2019 (COVID-19) pandemic has resulted in significant morbidity and mortality since its first case was discovered in December 2019. Since then, multiple countries have witnessed a healthcare system collapse due to the overwhelming demand for COVID-19 care. Drastic measures have been taken globally in order to curb the spread of the virus. However, those measures have led to the disruption of other aspects of healthcare, increasing the burden due to other medical conditions
    Document: The coronavirus disease 2019 (COVID-19) pandemic has resulted in significant morbidity and mortality since its first case was discovered in December 2019. Since then, multiple countries have witnessed a healthcare system collapse due to the overwhelming demand for COVID-19 care. Drastic measures have been taken globally in order to curb the spread of the virus. However, those measures have led to the disruption of other aspects of healthcare, increasing the burden due to other medical conditions. We have also stepped back in achieving the ambitious goal set in place by World Health Organization to eliminate viral hepatitis as a public threat by 2030. Hepatitis B and C are chronic conditions with a significant worldwide burden, and COVID-19 has resulted in many hepatitis elimination programs slowing or stopping altogether. In this review, we elucidate the impact of the ongoing COVID-19 pandemic on the interventions targeted towards the elimination of hepatitis B virus and hepatitis C virus. Some of the salient features that we have covered in this review include hindrance to screening and diagnostic tests, neonatal vaccinations, the transmission dynamics affecting hepatitis B virus and hepatitis C virus, role of limited awareness, restrictions to treatment accessibility, and disparity in healthcare services. We have highlighted the major issues and provided recommendations in order to tackle those challenges.

    Search related documents:
    Co phrase search for related documents
    • actual number and long term impact: 1
    • actual number and low income: 1
    • actual number and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and liver clinic: 1
    • acute respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
    • acute respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory distress syndrome and liver function test: 1, 2
    • acute respiratory distress syndrome and liver test: 1, 2, 3, 4
    • acute respiratory distress syndrome and long term impact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and long term mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory distress syndrome and long term mortality morbidity: 1, 2, 3, 4, 5
    • acute respiratory distress syndrome and low income: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory distress syndrome and low income country: 1
    • acute respiratory distress syndrome and low number: 1, 2, 3, 4, 5
    • adequate information and low income: 1, 2, 3, 4, 5, 6
    • adequate information and low number: 1, 2
    • liver clinic and long term impact: 1
    • liver disease and long term impact: 1, 2, 3, 4, 5
    • liver disease and long term mortality: 1, 2, 3, 4